APO Research
Talk to an analyst

APO RESEARCH · REPORT

Antihelminthics

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Antihelminthics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

19 December 2025199 pages

Choose your research edition.

Industry ResearchAntihelminthics Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Antihelminthics Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Antihelminthics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Antihelminthics Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Antihelminthics Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Antihelminthics market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Antihelminthics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Antihelminthics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Antihelminthics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Antihelminthics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Antihelminthics include Abbott, Sanofi, Sanofi, Johnson & Johnson, Novartis, Pfizer, GlaxoSmithKline, Bayer and AstraZeneca, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Antihelminthics market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Antihelminthics and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Antihelminthics sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Antihelminthics market size, projected growth trends, production technologies, key applications, and end-use industries.

Antihelminthics Segment by Company

Abbott

Sanofi

Sanofi

Johnson & Johnson

Novartis

Pfizer

GlaxoSmithKline

Bayer

AstraZeneca

ZEISS International

Merck & Co.

Mentis Pharma

Astellas Pharma

ALLERGAN

Antihelminthics Segment by Type

Salicylanilides

Benzimidazoles

Praziquantel

Abamectin

Other

Antihelminthics Segment by Application

Ascariasis

Giardiasis

Fasciolasis

Filariasis

Angiostrongylosis

Schistosomiasis

Other

Antihelminthics Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antihelminthics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Antihelminthics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antihelminthics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Antihelminthics market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Antihelminthics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Antihelminthics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Antihelminthics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Antihelminthics Industry Trends Table 2. Antihelminthics Industry Drivers Table 3. Antihelminthics Industry Opportunities and Challenges Table 4. Antihelminthics Industry Restraints Table 5. Global Antihelminthics Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Antihelminthics Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Antihelminthics Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Antihelminthics Sales Market Share by Manufacturers Table 9. Global Antihelminthics Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Antihelminthics Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Antihelminthics Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Antihelminthics Manufacturers, Product Type & Application Table 13. Global Antihelminthics Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Antihelminthics by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Salicylanilides Table 17. Major Manufacturers of Benzimidazoles Table 18. Major Manufacturers of Praziquantel Table 19. Major Manufacturers of Abamectin Table 20. Major Manufacturers of Other Table 21. Global Antihelminthics Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 22. Global Antihelminthics Sales by Type (2021-2026) & (K Units) Table 23. Global Antihelminthics Sales by Type (2027-2032) & (K Units) Table 24. Global Antihelminthics Sales Market Share by Type (2021-2026) Table 25. Global Antihelminthics Sales Market Share by Type (2027-2032) Table 26. Global Antihelminthics Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 27. Global Antihelminthics Revenue by Type (2021-2026) & (K Units) Table 28. Global Antihelminthics Revenue by Type (2027-2032) & (K Units) Table 29. Global Antihelminthics Revenue Market Share by Type (2021-2026) Table 30. Global Antihelminthics Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of Ascariasis Table 32. Major Manufacturers of Giardiasis Table 33. Major Manufacturers of Fasciolasis Table 34. Major Manufacturers of Filariasis Table 35. Major Manufacturers of Angiostrongylosis Table 36. Major Manufacturers of Schistosomiasis Table 37. Major Manufacturers of Other Table 38. Global Antihelminthics Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 39. Global Antihelminthics Sales by Application (2021-2026) & (K Units) Table 40. Global Antihelminthics Sales by Application (2027-2032) & (K Units) Table 41. Global Antihelminthics Sales Market Share by Application (2021-2026) Table 42. Global Antihelminthics Sales Market Share by Application (2027-2032) Table 43. Global Antihelminthics Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 44. Global Antihelminthics Revenue by Application (2021-2026) & (K Units) Table 45. Global Antihelminthics Revenue by Application (2027-2032) & (K Units) Table 46. Global Antihelminthics Revenue Market Share by Application (2021-2026) Table 47. Global Antihelminthics Revenue Market Share by Application (2027-2032) Table 48. Global Antihelminthics Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 49. Global Antihelminthics Sales by Region (2021-2026) & (K Units) Table 50. Global Antihelminthics Sales Market Share by Region (2021-2026) Table 51. Global Antihelminthics Sales Forecasted by Region (2027-2032) & (K Units) Table 52. Global Antihelminthics Sales Forecasted Market Share by Region (2027-2032) Table 53. North America Antihelminthics Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. North America Antihelminthics Sales by Country (2021-2026) & (K Units) Table 55. North America Antihelminthics Sales by Country (2027-2032) & (K Units) Table 56. Europe Antihelminthics Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. Europe Antihelminthics Sales by Country (2021-2026) & (K Units) Table 58. Europe Antihelminthics Sales by Country (2027-2032) & (K Units) Table 59. Asia Pacific Antihelminthics Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 60. Asia Pacific Antihelminthics Sales by Country (2021-2026) & (K Units) Table 61. Asia Pacific Antihelminthics Sales by Country (2027-2032) & (K Units) Table 62. South America, Middle East and Africa Antihelminthics Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 63. South America, Middle East and Africa Antihelminthics Sales by Country (2021-2026) & (K Units) Table 64. South America, Middle East and Africa Antihelminthics Sales by Country (2027-2032) & (K Units) Table 65. Global Antihelminthics Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 66. Global Antihelminthics Revenue by Region (2021-2026) & (US$ Million) Table 67. Global Antihelminthics Revenue by Region (2027-2032) & (US$ Million) Table 68. Global Antihelminthics Revenue Market Share by Region (2021-2026) Table 69. Global Antihelminthics Revenue Market Share by Region (2027-2032) Table 70. Abbott Company Information Table 71. Abbott Business Overview Table 72. Abbott Antihelminthics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Abbott Antihelminthics Product Portfolio Table 74. Abbott Recent Development Table 75. Sanofi Company Information Table 76. Sanofi Business Overview Table 77. Sanofi Antihelminthics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Sanofi Antihelminthics Product Portfolio Table 79. Sanofi Recent Development Table 80. Sanofi Company Information Table 81. Sanofi Business Overview Table 82. Sanofi Antihelminthics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Sanofi Antihelminthics Product Portfolio Table 84. Sanofi Recent Development Table 85. Johnson & Johnson Company Information Table 86. Johnson & Johnson Business Overview Table 87. Johnson & Johnson Antihelminthics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Johnson & Johnson Antihelminthics Product Portfolio Table 89. Johnson & Johnson Recent Development Table 90. Novartis Company Information Table 91. Novartis Business Overview Table 92. Novartis Antihelminthics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Novartis Antihelminthics Product Portfolio Table 94. Novartis Recent Development Table 95. Pfizer Company Information Table 96. Pfizer Business Overview Table 97. Pfizer Antihelminthics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Pfizer Antihelminthics Product Portfolio Table 99. Pfizer Recent Development Table 100. GlaxoSmithKline Company Information Table 101. GlaxoSmithKline Business Overview Table 102. GlaxoSmithKline Antihelminthics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. GlaxoSmithKline Antihelminthics Product Portfolio Table 104. GlaxoSmithKline Recent Development Table 105. Bayer Company Information Table 106. Bayer Business Overview Table 107. Bayer Antihelminthics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. Bayer Antihelminthics Product Portfolio Table 109. Bayer Recent Development Table 110. AstraZeneca Company Information Table 111. AstraZeneca Business Overview Table 112. AstraZeneca Antihelminthics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. AstraZeneca Antihelminthics Product Portfolio Table 114. AstraZeneca Recent Development Table 115. ZEISS International Company Information Table 116. ZEISS International Business Overview Table 117. ZEISS International Antihelminthics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 118. ZEISS International Antihelminthics Product Portfolio Table 119. ZEISS International Recent Development Table 120. Merck & Co. Company Information Table 121. Merck & Co. Business Overview Table 122. Merck & Co. Antihelminthics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 123. Merck & Co. Antihelminthics Product Portfolio Table 124. Merck & Co. Recent Development Table 125. Mentis Pharma Company Information Table 126. Mentis Pharma Business Overview Table 127. Mentis Pharma Antihelminthics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 128. Mentis Pharma Antihelminthics Product Portfolio Table 129. Mentis Pharma Recent Development Table 130. Astellas Pharma Company Information Table 131. Astellas Pharma Business Overview Table 132. Astellas Pharma Antihelminthics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 133. Astellas Pharma Antihelminthics Product Portfolio Table 134. Astellas Pharma Recent Development Table 135. ALLERGAN Company Information Table 136. ALLERGAN Business Overview Table 137. ALLERGAN Antihelminthics Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 138. ALLERGAN Antihelminthics Product Portfolio Table 139. ALLERGAN Recent Development Table 140. Key Raw Materials Table 141. Raw Materials Key Suppliers Table 142. Antihelminthics Distributors List Table 143. Antihelminthics Customers List Table 144. Research Programs/Design for This Report Table 145. Authors List of This Report Table 146. Secondary Sources Table 147. Primary Sources List of Figures Figure 1. Antihelminthics Product Image Figure 2. Global Antihelminthics Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Antihelminthics Market Size (2021-2032) & (US$ Million) Figure 4. Global Antihelminthics Sales (2021-2032) & (K Units) Figure 5. Global Antihelminthics Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Antihelminthics Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Salicylanilides Image Figure 9. Benzimidazoles Image Figure 10. Praziquantel Image Figure 11. Abamectin Image Figure 12. Other Image Figure 13. Global Antihelminthics Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Antihelminthics Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global Antihelminthics Sales Market Share by Type (2021-2032) Figure 16. Global Antihelminthics Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 17. Global Antihelminthics Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Antihelminthics Revenue Market Share by Type (2021-2032) Figure 19. Ascariasis Image Figure 20. Giardiasis Image Figure 21. Fasciolasis Image Figure 22. Filariasis Image Figure 23. Angiostrongylosis Image Figure 24. Schistosomiasis Image Figure 25. Other Image Figure 26. Global Antihelminthics Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 27. Global Antihelminthics Sales Market Share 2021 VS 2025 VS 2032 Figure 28. Global Antihelminthics Sales Market Share by Application (2021-2032) Figure 29. Global Antihelminthics Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 30. Global Antihelminthics Revenue Market Share 2021 VS 2025 VS 2032 Figure 31. Global Antihelminthics Revenue Market Share by Application (2021-2032) Figure 32. North America Antihelminthics Sales and Growth Rate (2021-2032) & (K Units) Figure 33. North America Antihelminthics Sales Market Share by Country (2021-2032) Figure 34. U.S. Antihelminthics Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Canada Antihelminthics Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Mexico Antihelminthics Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Europe Antihelminthics Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Europe Antihelminthics Sales Market Share by Country (2021-2032) Figure 39. Germany Antihelminthics Sales and Growth Rate (2021-2032) & (K Units) Figure 40. France Antihelminthics Sales and Growth Rate (2021-2032) & (K Units) Figure 41. U.K. Antihelminthics Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Italy Antihelminthics Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Netherlands Antihelminthics Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Asia Pacific Antihelminthics Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Asia Pacific Antihelminthics Sales Market Share by Country (2021-2032) Figure 46. China Antihelminthics Sales and Growth Rate (2021-2032) & (K Units) Figure 47. Japan Antihelminthics Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Korea Antihelminthics Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Southeast Asia Antihelminthics Sales and Growth Rate (2021-2032) & (K Units) Figure 50. India Antihelminthics Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Australia Antihelminthics Sales and Growth Rate (2021-2032) & (K Units) Figure 52. South America, Middle East and Africa Antihelminthics Sales and Growth Rate (2021-2032) & (K Units) Figure 53. South America, Middle East and Africa Antihelminthics Sales Market Share by Country (2021-2032) Figure 54. Brazil Antihelminthics Sales and Growth Rate (2021-2032) & (K Units) Figure 55. South Africa Antihelminthics Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Saudi Arabia Antihelminthics Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Turkey Antihelminthics Sales and Growth Rate (2021-2032) & (K Units) Figure 58. Argentina Antihelminthics Sales and Growth Rate (2021-2032) & (K Units) Figure 59. UAE Antihelminthics Sales and Growth Rate (2021-2032) & (K Units) Figure 60. Egypt Antihelminthics Sales and Growth Rate (2021-2032) & (K Units) Figure 61. Chile Antihelminthics Sales and Growth Rate (2021-2032) & (K Units) Figure 62. Global Antihelminthics Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 63. Global Antihelminthics Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 64. North America Antihelminthics Revenue (2021-2032) & (US$ Million) Figure 65. North America Antihelminthics Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Europe Antihelminthics Revenue (2021-2032) & (US$ Million) Figure 67. Europe Antihelminthics Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Asia-Pacific Antihelminthics Revenue (2021-2032) & (US$ Million) Figure 69. Asia-Pacific Antihelminthics Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 70. South America, Middle East and Africa Antihelminthics Revenue (2021-2032) & (US$ Million) Figure 71. South America, Middle East and Africa Antihelminthics Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 72. Antihelminthics Value Chain Figure 73. Manufacturing Cost Structure Figure 74. Antihelminthics Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • Salicylanilides
  • Benzimidazoles
  • Praziquantel
  • Abamectin
  • Other
Applications
  • Ascariasis
  • Giardiasis
  • Fasciolasis
  • Filariasis
  • Angiostrongylosis
  • Schistosomiasis
  • Other
Companies covered
  • Abbott
  • Sanofi
  • Sanofi
  • Johnson & Johnson
  • Novartis
  • Pfizer
  • GlaxoSmithKline
  • Bayer
  • AstraZeneca
  • ZEISS International
  • Merck & Co.
  • Mentis Pharma
  • Astellas Pharma
  • ALLERGAN

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Antihelminthics Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Antihelminthics Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Antihelminthics Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Antihelminthics Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Antihelminthics Market Dynamics
  1. 2.1 Antihelminthics Industry Trends
  2. 2.2 Antihelminthics Industry Drivers
  3. 2.3 Antihelminthics Industry Opportunities and Challenges
  4. 2.4 Antihelminthics Industry Restraints
3 Antihelminthics Market by Manufacturers
  1. 3.1 Global Antihelminthics Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Antihelminthics Sales by Manufacturers (2021-2026)
  3. 3.3 Global Antihelminthics Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Antihelminthics Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Antihelminthics Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Antihelminthics Manufacturers, Product Type & Application
  7. 3.7 Global Antihelminthics Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Antihelminthics Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Antihelminthics Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Antihelminthics Tier 1, Tier 2, and Tier 3
4 Antihelminthics Market by Type
  1. 4.1 Antihelminthics Type Introduction
  2. 4.1.1 Salicylanilides
  3. 4.1.2 Benzimidazoles
  4. 4.1.3 Praziquantel
  5. 4.1.4 Abamectin
  6. 4.1.5 Other
  7. 4.2 Global Antihelminthics Sales by Type
  8. 4.2.1 Global Antihelminthics Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Antihelminthics Sales by Type (2021-2032)
  10. 4.2.3 Global Antihelminthics Sales Market Share by Type (2021-2032)
  11. 4.3 Global Antihelminthics Revenue by Type
  12. 4.3.1 Global Antihelminthics Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Antihelminthics Revenue by Type (2021-2032)
  14. 4.3.3 Global Antihelminthics Revenue Market Share by Type (2021-2032)
5 Antihelminthics Market by Application
  1. 5.1 Antihelminthics Application Introduction
  2. 5.1.1 Ascariasis
  3. 5.1.2 Giardiasis
  4. 5.1.3 Fasciolasis
  5. 5.1.4 Filariasis
  6. 5.1.5 Angiostrongylosis
  7. 5.1.6 Schistosomiasis
  8. 5.1.7 Other
  9. 5.2 Global Antihelminthics Sales by Application
  10. 5.2.1 Global Antihelminthics Sales by Application (2021 VS 2025 VS 2032)
  11. 5.2.2 Global Antihelminthics Sales by Application (2021-2032)
  12. 5.2.3 Global Antihelminthics Sales Market Share by Application (2021-2032)
  13. 5.3 Global Antihelminthics Revenue by Application
  14. 5.3.1 Global Antihelminthics Revenue by Application (2021 VS 2025 VS 2032)
  15. 5.3.2 Global Antihelminthics Revenue by Application (2021-2032)
  16. 5.3.3 Global Antihelminthics Revenue Market Share by Application (2021-2032)
6 Global Antihelminthics Sales by Region
  1. 6.1 Global Antihelminthics Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Antihelminthics Sales by Region (2021-2032)
  3. 6.2.1 Global Antihelminthics Sales by Region (2021-2026)
  4. 6.2.2 Global Antihelminthics Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Antihelminthics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Antihelminthics Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Antihelminthics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Antihelminthics Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Antihelminthics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Antihelminthics Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Antihelminthics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Antihelminthics Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Antihelminthics Revenue by Region
  1. 7.1 Global Antihelminthics Revenue by Region
  2. 7.1.1 Global Antihelminthics Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Antihelminthics Revenue by Region (2021-2026)
  4. 7.1.3 Global Antihelminthics Revenue by Region (2027-2032)
  5. 7.1.4 Global Antihelminthics Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Antihelminthics Revenue (2021-2032)
  8. 7.2.2 North America Antihelminthics Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Antihelminthics Revenue (2021-2032)
  11. 7.3.2 Europe Antihelminthics Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Antihelminthics Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Antihelminthics Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Antihelminthics Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Antihelminthics Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Abbott
  2. 8.1.1 Abbott Company Information
  3. 8.1.2 Abbott Business Overview
  4. 8.1.3 Abbott Antihelminthics Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Abbott Antihelminthics Product Portfolio
  6. 8.1.5 Abbott Recent Developments
  7. 8.2 Sanofi
  8. 8.2.1 Sanofi Company Information
  9. 8.2.2 Sanofi Business Overview
  10. 8.2.3 Sanofi Antihelminthics Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Sanofi Antihelminthics Product Portfolio
  12. 8.2.5 Sanofi Recent Developments
  13. 8.3 Sanofi
  14. 8.3.1 Sanofi Company Information
  15. 8.3.2 Sanofi Business Overview
  16. 8.3.3 Sanofi Antihelminthics Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Sanofi Antihelminthics Product Portfolio
  18. 8.3.5 Sanofi Recent Developments
  19. 8.4 Johnson & Johnson
  20. 8.4.1 Johnson & Johnson Company Information
  21. 8.4.2 Johnson & Johnson Business Overview
  22. 8.4.3 Johnson & Johnson Antihelminthics Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Johnson & Johnson Antihelminthics Product Portfolio
  24. 8.4.5 Johnson & Johnson Recent Developments
  25. 8.5 Novartis
  26. 8.5.1 Novartis Company Information
  27. 8.5.2 Novartis Business Overview
  28. 8.5.3 Novartis Antihelminthics Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Novartis Antihelminthics Product Portfolio
  30. 8.5.5 Novartis Recent Developments
  31. 8.6 Pfizer
  32. 8.6.1 Pfizer Company Information
  33. 8.6.2 Pfizer Business Overview
  34. 8.6.3 Pfizer Antihelminthics Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Pfizer Antihelminthics Product Portfolio
  36. 8.6.5 Pfizer Recent Developments
  37. 8.7 GlaxoSmithKline
  38. 8.7.1 GlaxoSmithKline Company Information
  39. 8.7.2 GlaxoSmithKline Business Overview
  40. 8.7.3 GlaxoSmithKline Antihelminthics Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 GlaxoSmithKline Antihelminthics Product Portfolio
  42. 8.7.5 GlaxoSmithKline Recent Developments
  43. 8.8 Bayer
  44. 8.8.1 Bayer Company Information
  45. 8.8.2 Bayer Business Overview
  46. 8.8.3 Bayer Antihelminthics Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Bayer Antihelminthics Product Portfolio
  48. 8.8.5 Bayer Recent Developments
  49. 8.9 AstraZeneca
  50. 8.9.1 AstraZeneca Company Information
  51. 8.9.2 AstraZeneca Business Overview
  52. 8.9.3 AstraZeneca Antihelminthics Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 AstraZeneca Antihelminthics Product Portfolio
  54. 8.9.5 AstraZeneca Recent Developments
  55. 8.10 ZEISS International
  56. 8.10.1 ZEISS International Company Information
  57. 8.10.2 ZEISS International Business Overview
  58. 8.10.3 ZEISS International Antihelminthics Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 ZEISS International Antihelminthics Product Portfolio
  60. 8.10.5 ZEISS International Recent Developments
  61. 8.11 Merck & Co.
  62. 8.11.1 Merck & Co. Company Information
  63. 8.11.2 Merck & Co. Business Overview
  64. 8.11.3 Merck & Co. Antihelminthics Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Merck & Co. Antihelminthics Product Portfolio
  66. 8.11.5 Merck & Co. Recent Developments
  67. 8.12 Mentis Pharma
  68. 8.12.1 Mentis Pharma Company Information
  69. 8.12.2 Mentis Pharma Business Overview
  70. 8.12.3 Mentis Pharma Antihelminthics Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Mentis Pharma Antihelminthics Product Portfolio
  72. 8.12.5 Mentis Pharma Recent Developments
  73. 8.13 Astellas Pharma
  74. 8.13.1 Astellas Pharma Company Information
  75. 8.13.2 Astellas Pharma Business Overview
  76. 8.13.3 Astellas Pharma Antihelminthics Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Astellas Pharma Antihelminthics Product Portfolio
  78. 8.13.5 Astellas Pharma Recent Developments
  79. 8.14 ALLERGAN
  80. 8.14.1 ALLERGAN Company Information
  81. 8.14.2 ALLERGAN Business Overview
  82. 8.14.3 ALLERGAN Antihelminthics Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 ALLERGAN Antihelminthics Product Portfolio
  84. 8.14.5 ALLERGAN Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Antihelminthics Value Chain Analysis
  2. 9.1.1 Antihelminthics Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Antihelminthics Production Mode & Process
  6. 9.2 Antihelminthics Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Antihelminthics Distributors
  9. 9.2.3 Antihelminthics Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst